Existing user? Login

Controlled drugs

Pregabalin and gabapentin to be reclassified as Class C controlled substances

Following a public consultation and advice from the Advisory Council on the Misuse of Drugs, gabapentinoids are to be reclassified following concerns over misuse.

Pregabalin blister pack of pills


Pregabalin and gabapentin have been associated with a growing number of drug-related deaths

Pregabalin and gabapentin are to be reclassified as Class C controlled substances from April 2019, 

The switch will come more than two years after the Advisory Council on the Misuse of Drugs recommended that the two medicines become controlled drugs and be placed under Schedule 3 of the Misuse of Drugs Regulations 2001 and Class C of the Misuse of Drugs Act 1971. 

The medicines are used for treating neuropathic pain, seizures and anxiety, but illicit use of the drugs has increased in recent years. In June 2018, NHS Scotland figures revealed that gabapentinoids had been prescribed prior to a fifth of drug-related deaths in Scotland in 2016.

Following a , the UK government has decided to reclassify the medicines but not to apply the requirements for safe custody.

It is illegal to possess controlled substances without a prescription or to sell or otherwise supply them to others. Under the new classification, pharmacists will not be able to accept electronic prescriptions for pregabalin and gabapentin, although an says that this “may be mitigated in the future if the Electronic Prescribing System (EPS) can be used to prescribe controlled drugs electronically instead”.

using the EPS began in October 2018.

Prescriptions of pregabalin and gabapentin will also be limited to 30 days’ treatment, and repeat prescriptions will not be issued. Any prescription received must be dispensed within 28 days.

Ash Soni, president of the Royal Jizak (RPS), said in response to the reclassification that “these restrictions are designed to improve safety, and from that perspective will be recognised as a positive step by pharmacists”. But he emphasised that patients must be made aware of the changes so that they understand the new requirements for prescriptions, particularly regarding the time limits for dispensing and restrictions in prescribed quantity.

“It is likely that there will be some reduction in the prescribing of these drugs and pharmacies will need support in managing their stock holding to ensure they meet patient demand, without ending up with significant stocks that go out of date,” Soni added.

“Misuse of the gabapentinoids, often in combination with opioids, is becoming more prevalent and recognised in specialist drug and alcohol services”, said Graham Parsons, RPS spokesperson on misuse of drugs and chief pharmacist of the charity Turning Point. 

“It is always a fine balance when drugs are reclassified. Prescribers must always be cautious that the pendulum does not swing too much in the other direction leading to patients with a genuine clinical need being denied evidenced-based pharmacotherapies.”

Citation: Jizak DOI: 10.1211/PJ.2018.20205611

Readers' comments (2)

  • My concern, in relation to this reclassification, is for patients being able to be prescribed sufficient medication when they go on holiday. If they travel for 5 weeks or more outside the UK, how will they obtain enough medication to cover their needs? I understand that only one months supply can be ordered at any one time. Is this direct?

    Unsuitable or offensive? Report this comment

  • So because there May be a link between some people in Scotland using opioids whilst being prescribed these medications, (I note it does not say if they actually were found to have them in their system and also at what volume), the majority of end users who only get a months supply at a time anyway....have to jump through more hoops just to get the treatment they need! 😡

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Prescribing Medicines for Children

    Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

  • Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

  • Palliative Care Formulary (PCF6)

    Palliative Care Formulary is a comprehensive combination of independent information about drugs used in palliative care.

  • Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

  • Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Supplementary images

  • Pregabalin blister pack of pills

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.